Reproductive late effects and testosterone replacement therapy in male childhood cancer survivors: A population-based study (the Fex-Can study)

Nowadays, most children with cancer survive, but many experience long-term effects from their cancer treatment. Treatments like conditioning therapy for hematopoietic stem cell transplantation, high cumulative doses of alkylating agents and radiation can damage the gonads, leading to problems such as infertility and delayed puberty in males. Identifying and addressing these issues in follow-up care …

Read more

Tête-à-tête with Aurore Roland

Meet Aurore Roland, our guide into the science behind good sleep at the upcoming 16th NYRA Meeting in Brussels (May 27th-29th). Dra. Aurore Roland obtained her master’s degree in clinical psychology from the Vrije Universiteit Brussel (VUB) in 2021. The same year she became a European Sleep Research Society-certified expert in behavioural sleep medicine. She …

Read more

Tête-à-tête with Herman Tournaye

Get to know Dr Herman Tournaye, one of the invited speakers to the upcoming 16th NYRA Meeting in Brussels (May 27th-29th), through this interview. Prof. Tournaye is the Medical and Scientific Director of Brussels IVF and a Professor at the Vrije Universiteit Brussel (VUB). His research focuses on spermatogenesis and testicular stem cells. When and why …

Read more

Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort

For young boys with cancer or a non-malignant hematological disorder, conditioning therapy, abdominal/pelvic radiotherapy, and certain chemotherapies form a major risk for germ cell loss. Contradictory studies have investigated the direct effects of such diseases on the development of the prepubertal male gonad before mainline treatment. For health professionals to counsel pediatric patients in the …

Read more